| 000 | 01924 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516204920.0 | ||
| 264 | 0 | _c20140703 | |
| 008 | 201407s 0 0 eng d | ||
| 022 | _a1879-0852 | ||
| 024 | 7 |
_a10.1016/j.ejca.2014.03.011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpijkers-Hagelstein, Jill A P | |
| 245 | 0 | 0 |
_aGlucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cJun 2014 |
||
| 300 |
_a1665-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xgenetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aGene Order _xgenetics |
| 650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
| 650 | 0 | 4 |
_aGossypol _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLeukemia, Biphenotypic, Acute _xdrug therapy |
| 650 | 0 | 4 |
_aMyeloid Cell Leukemia Sequence 1 Protein _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aPrednisolone _xtherapeutic use |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_aSirolimus _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aSchneider, Pauline | |
| 700 | 1 | _aPinhanços, Sandra Mimoso | |
| 700 | 1 | _aGarrido Castro, Patricia | |
| 700 | 1 | _aPieters, Rob | |
| 700 | 1 | _aStam, Ronald W | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 50 _gno. 9 _gp. 1665-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2014.03.011 _zAvailable from publisher's website |
| 999 |
_c23710070 _d23710070 |
||